Search research articles
Contact Us
Filters
Showing results (91-100 of 180) with videos related to
Page
of 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 1997
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A
G Tortora, R Caputo, V Damiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy
F Ciardiello, T Troiani, R Bianco, et al.
Expert Opinion on Pharmacotherapy
|
February 23, 2016
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
R Ferrara, S Pilotto, U Peretti, et al.
International Journal of Cancer
|
February 1, 1993
Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes
F Ciardiello, S Pepe, C Bianco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor
F Ciardiello, R Caputo, R Bianco, et al.
International Journal of Oncology
|
May 10, 2011
Overexpression of wild-type p53 overrides the mitogenic effect of ri-alpha subunit of protein-kinase-a in human breast cells
V Damiano, G Diisernia, F Ciardiello, et al.
Medical Oncology (Northwood, London, England)
|
July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement
C Porta, G Tortora, C Linassier, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
Reduction of RI alpha subunit of cAMP-dependent protein kinase expression induces growth inhibition of human mammary epithelial cells transformed by TGF-alpha, c-Ha-ras, and c-erbB-2 genes
F Ciardiello, G Tortora, S Pepe, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 14, 2015
New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors
C Ciccarese, S Alfieri, M Santoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis
G Tortora, R Caputo, V Damiano, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 180) with videos related to
Sort By:
Page
of 18
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 1997
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A
G Tortora, R Caputo, V Damiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy
F Ciardiello, T Troiani, R Bianco, et al.
Expert Opinion on Pharmacotherapy
|
February 23, 2016
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
R Ferrara, S Pilotto, U Peretti, et al.
International Journal of Cancer
|
February 1, 1993
Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes
F Ciardiello, S Pepe, C Bianco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor
F Ciardiello, R Caputo, R Bianco, et al.
International Journal of Oncology
|
May 10, 2011
Overexpression of wild-type p53 overrides the mitogenic effect of ri-alpha subunit of protein-kinase-a in human breast cells
V Damiano, G Diisernia, F Ciardiello, et al.
Medical Oncology (Northwood, London, England)
|
July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement
C Porta, G Tortora, C Linassier, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
Reduction of RI alpha subunit of cAMP-dependent protein kinase expression induces growth inhibition of human mammary epithelial cells transformed by TGF-alpha, c-Ha-ras, and c-erbB-2 genes
F Ciardiello, G Tortora, S Pepe, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 14, 2015
New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors
C Ciccarese, S Alfieri, M Santoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis
G Tortora, R Caputo, V Damiano, et al.
Page
of 18